Dear clients,
We would like to announce that starting today, December 1, 2023, the price of the molecular test for screening and genotyping for 19 high-risk and 9 low-risk types of the HPV virus will be reduced to 3,100 denars.
The test uses the most modern Multiplex real-time PCR technology for highly sensitive and specific molecular detection and genotyping of the HPV virus (Human papillomavirus).
The test is the most comprehensive solution on the market and detects:
19 HIGH RISK TYPES OF HPV
(16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 69, 73, 82)
9 LOW RISK TYPES OF HPV
(6,11, 40, 42, 43, 44, 54, 61, 70)
This test meets all international criteria and guidelines for primary screening for cervical cancer. Read more about the HPV virus at the following link.